Log in
Enquire now
‌

US Patent 8735419 Forms of rifaximin and uses thereof

Patent 8735419 was granted and assigned to Salix Pharmaceuticals on May, 2014 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Current Assignee
‌
Salix Pharmaceuticals
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
8735419
Patent Inventor Names
Yiduo Wu0
Patricia Andres0
Paul Schields0
Stephan D. Parent0
Fei Ding0
Jared P. Smit0
Lisa L. McQueen0
Date of Patent
May 27, 2014
Patent Application Number
13371238
Date Filed
February 10, 2012
Patent Primary Examiner
‌
Bruck Kifle
Patent abstract

Embodiments relate to Rifaximin polymorphic, salt, and hydrate forms, methods of producing polymorphic forms and to their use in medicinal preparations and to therapeutic methods using them.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 8735419 Forms of rifaximin and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us